Africa Asia Middle East عربي Français Português Subscribe RSS IRIN Site Map
Global HIV/AIDS news and analysis
Advanced search
 Tuesday 23 June 2009
Weekly reports 
In-Depth reports 
Country profiles 
Fact files 
Most read 
Print report
GLOBAL: Is there still hope for an HIV vaccine?

Photo: Kristy Siegfried/PlusNews
A volunteer receives a dose of a trial HIV vaccine
MEXICO CITY, 5 August 2008 (PlusNews) - The road to finding an effective HIV vaccine has recently been marked by a string of disappointing setbacks, and researchers have warned that a breakthrough in this field is still a long way off. Should we give up hope?

Delegates at the International AIDS Conference in Mexico City heard on Monday that the search for a vaccine to protect against HIV infection was one of the most difficult endeavours ever, with vaccine science still "more an art than a science".

In the past year, one major vaccine trial was halted after early results showed that not only did the candidate not protect people from the virus, it may actually have put them at increased risk of becoming infected.

Last month, the US National Institute of Allergy and Infectious Diseases (NIAID) announced it would not move ahead with a vaccine trial involving 8,500 participants, which was intended to test a candidate with similarities to the one that failed last year.

These developments have left the vaccine field reeling, with people in some quarters calling for public funding of AIDS vaccine research to be ended or diverted toward existing HIV treatment and prevention interventions.

But Tachi Yamada, executive director of the Bill and Melinda Gates Foundation's Global Health Programme, a major funder of vaccine research, told delegates that the recent failures in HIV vaccine trials were no reason to give up hope.

''This is not a time to step away and invest less...we need to move forward with big investments''
"This is not a time to step away and invest less...we need to move forward with big investments. We have to be unafraid to fail," he said.

According to Yamada, scientists have very little predictive knowledge of whether vaccine candidates will work. He called for better animal models for the testing of candidate vaccines, as existing models could not predict effects on humans.

Another challenge for clinical trials was that participants did not always follow instructions, making it more difficult to demonstrate a vaccine's effects.

Unrealistic expectations on the part of the public also continued to be a problem. "When a trial goes wrong, the immediate assumption is that it was a bad investment," said Yamada, who called for more to be done to educate the public about HIV prevention research.

Alan Bernstein, director of the Global HIV Vaccine Enterprise, admitted that the search for an effective vaccine was "at a critical crossroads". He told delegates that the challenge now was to design trials that would "advance our understanding of the human immune response to HIV".


See also: Trials and Tribulations of HIV Prevention Research

Theme(s): (PLUSNEWS) HIV/AIDS (PlusNews), (PLUSNEWS) Prevention - PlusNews


[This report does not necessarily reflect the views of the United Nations]
Print report
FREE Subscriptions
Your e-mail address:

Submit your request
 More on AFRICA
GLOBAL: IRIN/PlusNews Weekly Issue 442, 19 June 2009
AFRICA: Award for NGO using dance in HIV prevention
GLOBAL: Economic crisis no excuse to cut funds - UN
GLOBAL: Promising new drug to treat TB
GLOBAL: IRIN/PlusNews Weekly Issue 441, 12 June 2009
 More on HIV/AIDS (PlusNews)
SOUTH AFRICA: Serious shortage in ARV funding
GLOBAL: IRIN/PlusNews Weekly Issue 442, 19 June 2009
AFRICA: Award for NGO using dance in HIV prevention
MOZAMBIQUE: Islamic schools join HIV prevention efforts
BOTSWANA: Significant impact in widespread circumcision - study
Back | Home page

Services:  Africa | Asia | Middle East | Radio | Film & TV | Photo | Live news map | E-mail subscription
Feedback · E-mail Webmaster · IRIN Terms & Conditions · Really Simple Syndication News Feeds · About PlusNews · Jobs · Bookmark PlusNews · Donors

Copyright © IRIN 2009
This material comes to you via IRIN, the humanitarian news and analysis service of the UN Office for the Coordination of Humanitarian Affairs. The opinions expressed do not necessarily reflect those of the United Nations or its Member States. Republication is subject to terms and conditions as set out in the IRIN copyright page.